MONTE ROSA THERAPEUTICS INC's ticker is GLUE and the CUSIP is 61225M102. A total of 74 filers reported holding MONTE ROSA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,854 | -14.0% | 34,625 | +23.0% | 0.00% | – |
| Q2 2023 | $192,868 | +201.2% | 28,156 | +242.6% | 0.00% | – |
| Q1 2023 | $64,026 | +13.1% | 8,219 | +10.5% | 0.00% | – |
| Q4 2022 | $56,603 | -0.7% | 7,438 | +5.4% | 0.00% | – |
| Q3 2022 | $57,000 | -14.9% | 7,054 | +1.9% | 0.00% | – |
| Q2 2022 | $67,000 | -4.3% | 6,924 | +38.7% | 0.00% | – |
| Q1 2022 | $70,000 | +2.9% | 4,993 | +50.5% | 0.00% | – |
| Q4 2021 | $68,000 | +183.3% | 3,317 | +206.6% | 0.00% | – |
| Q3 2021 | $24,000 | -65.2% | 1,082 | -63.9% | 0.00% | – |
| Q2 2021 | $69,000 | – | 3,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aisling Capital Management LP | 1,472,331 | $12,029,000 | 7.99% |
| NEA Management Company, LLC | 7,703,205 | $62,935,000 | 3.14% |
| Cormorant Asset Management, LP | 2,993,717 | $24,459,000 | 1.71% |
| Alphabet Inc. | 1,464,015 | $11,961,000 | 0.61% |
| Avoro Capital Advisors LLC | 3,363,333 | $27,478,000 | 0.51% |
| Casdin Capital, LLC | 510,882 | $4,174,000 | 0.27% |
| RTW INVESTMENTS, LP | 1,214,572 | $9,923,000 | 0.23% |
| Woodline Partners LP | 502,411 | $4,105,000 | 0.06% |
| Virtus Investment Advisers, Inc. | 12,638 | $103,000 | 0.05% |
| CORNERCAP INVESTMENT COUNSEL INC | 28,192 | $230,000 | 0.04% |